Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT03982992
What this trial is testing

Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab

Who this might be right for
B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell TransplantationB-Cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia+2 more
Ludwig-Maximilians - University of Munich
Not applicableStudy completedNCT03532971
What this trial is testing

Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

Who this might be right for
BK Virus Infection
Dana-Farber Cancer Institute 100
Testing effectiveness (Phase 2)Study completedNCT02572167
What this trial is testing

Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 93
Testing effectiveness (Phase 2)Looking for participantsNCT06532084
What this trial is testing

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

Who this might be right for
Acute Myeloid Leukemia, in RelapseMyelodysplastic SyndromesChronic Myeloid Leukemia+1 more
St. Petersburg State Pavlov Medical University 88
Not applicableUnknownNCT04502628
What this trial is testing

Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis Post HSCT

Who this might be right for
Stem Cell Transplant Complications
Shandong Provincial Hospital 150
Testing effectiveness (Phase 2)Ended earlyNCT00143884
What this trial is testing

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Who this might be right for
LeukemiaLymphoma, Low-GradeLymphoma, Non-Hodgkin's+2 more
University of Michigan Rogel Cancer Center 30
Not applicableStudy completedNCT03288844
What this trial is testing

Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns

Who this might be right for
Limbal Stem Cell Deficiency Due to Ocular Burn
Holostem s.r.l. 47
Not applicableStudy completedNCT01930981
What this trial is testing

Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life

Who this might be right for
Hematologic MalignanciesOther Diagnoses, Comorbidities, and Complications
Fred Hutchinson Cancer Center 252
Not applicableStudy completedNCT06256341
What this trial is testing

HHV-6-specific T-cell Reconstitution Among Children and Adolescents After Allogeneic Stem.

Who this might be right for
Allogeneic Stem Cell Transplantation
Medical University of Graz 53
Testing effectiveness (Phase 2)UnknownNCT04622956
What this trial is testing

GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide

Who this might be right for
Graft Vs Host DiseaseHematopoietic Neoplasm
University of Sao Paulo General Hospital 47
Testing effectiveness (Phase 2)Study completedNCT01058239
What this trial is testing

Bortezomib Plus Rituximab for EBV+ PTLD

Who this might be right for
Post-transplant Lymphoproliferative DiseaseSolid Organ TransplantStem Cell Transplant (Bone Marrow Transplant)+1 more
Massachusetts General Hospital 7
Not applicableLooking for participantsNCT06512519
What this trial is testing

Second Haplo-transplantation for Graft Failure

Who this might be right for
Graft FailureStem Cell Transplant Complications
Peking University People's Hospital 34
Large-scale testing (Phase 3)Study completedNCT00430365
What this trial is testing

Maintenance Therapy Using Lenalidomide in Myeloma

Who this might be right for
Myeloma
University Hospital, Toulouse 614
Not applicableNot Yet RecruitingNCT07140445
What this trial is testing

Monitoring Neurocognitive Dysfunction and the Impact of Metabolism and Physical Capacity After Paediatric HSCT

Who this might be right for
Stem Cell TransplantLate EffectNeurocognitive Dysfunction+3 more
Rigshospitalet, Denmark 175
Testing effectiveness (Phase 2)Study completedNCT00032292
What this trial is testing

Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Facet Biotech 34
Testing effectiveness (Phase 2)Study completedNCT01816971
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
University of Chicago 76
Testing effectiveness (Phase 2)Looking for participantsNCT06107738
What this trial is testing

Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Barbara Ann Karmanos Cancer Institute 60
Not applicableUnknownNCT05601895
What this trial is testing

The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib Maintenance

Who this might be right for
Acute LeukemiaAllogeneic Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 60
Not applicableUnknownNCT04711967
What this trial is testing

Prospective Study of FMT for Acute Intestinal GVHD After Allo-HSCT

Who this might be right for
Acute Graft Versus Host Disease in Intestine
Qilu Hospital of Shandong University 20
Testing effectiveness (Phase 2)WithdrawnNCT04230031
What this trial is testing

Phase II Study of Daratumumab Pre-Mobilization and Post-ASCT in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences
Next Page